Physician profile
Darrell Rubin
NPI 1700095072
$568.98
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $410 · 2023: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $132.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $119.30 | 2022-2023 | Camzyos, Eliquis |
| Cvrx, INC. | $100.88 | 2022-2023 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $62.27 | 2022-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $53.03 | 2023 | |
| Pfizer INC. | $38.53 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.66 | 2022 | |
| Merck Sharp & Dohme LLC | $18.23 | 2022 | |
| Amgen INC. | $14.91 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.